Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEG Biomarkers of Response in Depression
NCT00759122Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Nov 2002
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Nov 2002; status: completed.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00759122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759122.